Wird geladen...
PSMA Theranostics: Current Status and Future Directions
Prostate-specific membrane antigen (PSMA) is a promising target for imaging diagnostics and targeted radionuclide therapy (theranostics) of prostate cancer and its metastases. There is increasing evidence of encouraging response rates and a low toxicity profile of radioligand therapy (RLT) of metast...
Gespeichert in:
| Veröffentlicht in: | Mol Imaging |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5992796/ https://ncbi.nlm.nih.gov/pubmed/29873291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1536012118776068 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|